Stents
Total Trials
20
As Lead Sponsor
18
As Collaborator
2
Total Enrollment
9,679
NCT00792753
"Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study EXCELLA II STUDY"
Phase: N/A
Role: Lead Sponsor
Start: Oct 31, 2008
Completion: Mar 8, 2014
NCT02086006
Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial
Start: Feb 28, 2011
Completion: Apr 30, 2017
NCT02086045
Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial
Start: Nov 30, 2011
Completion: May 15, 2017
NCT02009956
EXCELLA Post-Approval Study
Start: Feb 26, 2014
Completion: Jun 1, 2016
NCT02013349
DESolve Post-Approval Study
Start: Apr 22, 2014
Completion: Apr 1, 2019
NCT02453035
DESolve® X-Pand Global Post Market Registry
Start: May 13, 2015
NCT04034121
Elixir Medical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - Cx Registry
Start: Jan 20, 2016
Completion: Sep 30, 2020
NCT02869087
The DESappear Study: Drug Eluting Scaffold
Start: Oct 10, 2016
Completion: Apr 30, 2021
NCT03429894
Evaluation of a Thin Strut Metallic Stent: the Elixir DynamX Clinical Study
Start: Nov 16, 2017
Completion: Dec 31, 2021
NCT03634020
DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System
Start: Dec 10, 2018
Completion: Mar 8, 2021
NCT03163485
Hybrid Device DIALYTRODE for Multimodal Neuro-monitoring of Patients With Brain Injury and Status Epilepticus
Role: Collaborator
Start: Mar 31, 2019
Completion: Jul 25, 2020
NCT04375085
DESyne X2 Post Market Follow-up Study
Start: Sep 1, 2020
Completion: Dec 28, 2021
NCT04483791
DynamX Bioadaptor Hong Kong Registry
Phase: Phase 4
Start: Sep 30, 2020
Completion: Dec 31, 2022
NCT04562805
Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
Completion: Jul 31, 2028
NCT04192747
The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries
Start: Dec 16, 2020
Completion: Feb 28, 2027
NCT05464147
DYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions
Start: Oct 19, 2021
Completion: Oct 31, 2024
NCT05033964
The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions
Phase: Phase 2
Start: Dec 15, 2021
Completion: Mar 31, 2026
NCT05828173
A Clinical Trial to Assess the Elixir Medical LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter
Start: Apr 27, 2023
Completion: Sep 9, 2024
NCT06105645
Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy
Start: Jan 19, 2024
Completion: Apr 30, 2030
NCT06074549
DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System
Start: Mar 10, 2024
Completion: Dec 31, 2028
Loading map...